Skip to main content
. 2013 Oct 29;11:184. doi: 10.1186/1477-7525-11-184

Figure 1.

Figure 1

Model for the use of PRO data to inform patient care. Major routes are indicated by solid arrows whilst other possible routes are indicated by unfilled arrows. The potential impact of the CONSORT PRO Extension on evidence from clinical trials and links to guideline development are indicated. Adapted from Till et al. [3].